Related Experiment Video
Updated: Mar 29, 2026

Acupoint Catgut Embedding Therapy in Traditional Chinese Medicine for Managing Allergic Rhinitis
Published on: December 20, 2024
ALLERGIC RHINITIS AND ADENOID HYPERTROPHY IN CHILDREN: IS ADENOIDECTOMY ALWAYS REALLY USEFUL?
L Colavita1, M Miraglia Del Giudice2, G Stroscio3
11 Department of Pediatrics, Unit of Genetics and Pediatric Immunology, University of Messina, Policlinico G. Martino, Messina, Italy.
Insights
Adenoidectomy offers limited benefits for children with allergic rhinitis (AR) and adenoid hypertrophy (AH). Medical anti-allergic therapy is crucial for managing local inflammation and improving nasal symptoms in pediatric patients.
Area of Science:
- Pediatric Otolaryngology
- Allergy and Immunology
- Pediatric Respiratory Medicine
Background:
- Allergic rhinitis (AR) and adenoid hypertrophy (AH) frequently coexist in children.
- Medical anti-allergic therapy has shown promise in improving respiratory symptoms and reducing adenoid volume.
Purpose of the Study:
- To retrospectively evaluate the effectiveness of adenoidectomy on respiratory symptoms in pediatric patients diagnosed with allergic rhinitis.
Main Methods:
- Recruited 404 pediatric patients with AR, classified into four groups based on ARIA criteria.
- Assessed patient history, allergy markers (IgE, SPT), and presence of AH via fibroscopy.
- Evaluated adenoidectomy efficacy on respiratory symptoms post-surgery.
Main Results:
- A significant association was found between AR and AH, with 22% of AR patients exhibiting significant AH.
- Adenoidectomy provided unsatisfactory benefits for 80% of AR patients, with persistent or recurrent rhinitic symptoms.
- Common post-adenoidectomy issues included persistent nasal obstruction and recurrent respiratory tract infections.
Conclusions:
- Adenoidectomy is often ineffective as a primary treatment for pediatric AR with AH due to persistent local inflammation.
- Medical anti-allergic therapy is essential to manage nasal mucosal and adenoid inflammation.
- Treating local inflammation medically is key to improving symptoms and preventing adenoid regrowth.
Abstract:
Allergic rhinitis (AR) and adenoid hypertrophy (AH) are common in children and are often associated with each other. Recent studies have shown improvement of respiratory symptoms and reduction in the adenoid volume after anti-allergic medical therapy (intranasal corticosteroids, antihistamines). The aim of our retrospective study is to evaluate the effectiveness of adenoidectomy on respiratory symptoms in pediatric patients with AR. We recruited 404 pediatric patients with AR, and we divided them into 4 groups (1. intermittent-mild rhinitis; 2. intermittent-moderate/severe rhinitis; 3. persistent-mild rhinitis; 4. persistent-moderate/severe rhinitis), using ARIA classification. For each patient we evaluated: age at onset of AR; family history of allergy; the presence of other allergic diseases; serum total IgE values; skin prick test (SPT) results; presence of AH evaluated by rhino-laringeal fibroscopy; adenoidectomy and its efficacy on respiratory symptoms. Our data show an association between AR and AH: 90 of 404 (22%) children with AR had AH of a degree greater than 2nd. A significant percentage (80%) of children suffering from AR did not present satisfactory benefits from adenoidectomy. They reported persistence or recurrence of rhinitic symptoms after surgery or only partial benefits, especially of recurrent respiratory tract infections and nasal obstruction. The local allergic persistent inflammation on nasal mucosa and adenoid tissue is probably the cause of the unsatisfactory results of adenoidectomy, therefore surgery cannot be the first therapeutic step for these children. It is important to extinguish the local inflammation by medical anti-allergic therapy to obtain improvements of nasal symptoms and to prevent adenoid regrowth.
Related Concept Videos
Chronic Pharyngitis
Etiology
It often arises from persistent viral or bacterial infections affecting sinuses and tonsils.
Additional contributing factors include inadequate dental hygiene, mouth breathing, recurring tonsillitis, allergic rhinitis, laryngopharyngeal reflux, and exposure to smoke, chemicals, and other environmental pollutants. Allergic reactions to pollen, mold, and pet dander, chronic cough, excessive voice usage,...
Drugs Used in Upper Respiratory Disorders: Overview
Antihistamines (e.g., Benadryl) block histamines from binding. Histamines are chemicals released during an allergic reaction in the body. As a...
Upper Respiratory Drugs: Decongestants
Most decongestants are readily available over-the-counter in...
Adrenergic Agonists: Therapeutic Uses
Emergency and Intensive Care Unit (ICU) applications: Pressor agents increase blood pressure, heart rate, and contractility in shock and organ failure situations. Dopamine can induce vasodilation and stimulate adrenoceptors. Endogenous catecholamines are effective in treating cardiogenic shock. α2-agonists like clonidine can reverse anesthesia-induced hypertension.
Allergies and...
Adrenergic Agonists: Mixed-Action Agents
Ephedrine and pseudoephedrine lack a catecholamine group, making them less susceptible to degradation by metabolic enzymes. They have increased oral bioavailability and lipophilicity, resulting in a longer duration of action. Their response is reduced by...
Adrenergic Agonists: Therapeutic Classification
Vasopressor or pressor agents: They increase blood pressure and function as cardiac stimulants. Examples include endogenous catecholamines (norepinephrine and dopamine) and synthetic agents (phenylephrine).
Bronchodilators: β2-agonists can relax bronchial muscles and widen airways. They are commonly used for treating obstructive pulmonary...

